US 12,318,617 B2
Electrical stimulation therapy
Rene A. Molina, Maple Grove, MN (US); Robert S. Raike, Minneapolis, MN (US); Benjamin P. Isaacson, Mahtomedi, MN (US); Christopher L. Pulliam, Plymouth, MN (US); Abbey Beuning Holt Becker, Shoreview, MN (US); and Michelle A. Case, Blaine, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Feb. 21, 2022, as Appl. No. 17/651,888.
Claims priority of provisional application 63/152,984, filed on Feb. 24, 2021.
Prior Publication US 2022/0266032 A1, Aug. 25, 2022
Int. Cl. A61N 1/36 (2006.01); A61N 1/02 (2006.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01)
CPC A61N 1/36178 (2013.01) [A61N 1/025 (2013.01); A61N 1/0534 (2013.01); A61N 1/36185 (2013.01); A61N 1/37235 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A medical device for providing electrical stimulation to a brain of a patient, the medical device comprising one or more processors configured to:
determine a first timing associated with a first burst of pulses for a first electrical signal deliverable to a first region of the brain;
determine a second timing, following the first timing, associated with a second burst of pulses for a second electrical signal deliverable to a second region of the brain using, as input,
a determined strength of synchrony between the first region of the brain and the second region of the brain;
deliver, at the first timing via a first electrode, the first electrical signal to the first region of the brain; and
deliver, at the second timing via a second electrode, the second electrical signal to the second region of the brain.